DekaBank Deutsche Girozentrale Grows Position in Envista Holdings Co. (NYSE:NVST)

Posted by Defense World Staff on Apr 21st, 2023

DekaBank Deutsche Girozentrale raised its holdings in shares of Envista Holdings Co. (NYSE:NVST – Get Rating) by 208.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 74,029 shares of the company’s stock after buying an additional 50,000 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Envista were worth $2,468,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of NVST. Raymond James & Associates grew its holdings in shares of Envista by 6.1% during the first quarter. Raymond James & Associates now owns 56,493 shares of the company’s stock worth $2,752,000 after buying an additional 3,235 shares in the last quarter. Bank of Montreal Can grew its holdings in shares of Envista by 13.9% in the first quarter. Bank of Montreal Can now owns 124,799 shares of the company’s stock valued at $6,103,000 after purchasing an additional 15,228 shares during the period. Panagora Asset Management Inc. grew its holdings in shares of Envista by 8.1% in the first quarter. Panagora Asset Management Inc. now owns 6,543 shares of the company’s stock valued at $319,000 after purchasing an additional 490 shares during the period. Great West Life Assurance Co. Can grew its holdings in shares of Envista by 8.6% in the first quarter. Great West Life Assurance Co. Can now owns 88,474 shares of the company’s stock valued at $4,433,000 after purchasing an additional 7,020 shares during the period. Finally, Vontobel Holding Ltd. purchased a new stake in shares of Envista in the first quarter valued at about $390,000.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Robert W. Baird upped their price objective on shares of Envista from $38.00 to $43.00 and gave the company a “neutral” rating in a report on Thursday, February 9th. Piper Sandler upped their price objective on shares of Envista from $42.00 to $46.00 and gave the company an “overweight” rating in a report on Monday, February 6th. Finally, TheStreet raised shares of Envista from a “c+” rating to a “b” rating in a report on Wednesday, February 8th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, Envista presently has a consensus rating of “Moderate Buy” and a consensus price target of $46.00.

Insider Transactions at Envista

In other news, CFO Howard H. Yu sold 10,016 shares of the stock in a transaction dated Tuesday, February 28th. The shares were sold at an average price of $37.90, for a total transaction of $379,606.40. Following the sale, the chief financial officer now owns 45,865 shares of the company’s stock, valued at $1,738,283.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.76% of the company’s stock.

Envista Trading Down 0.2 %

Shares of NVST stock opened at $38.20 on Friday. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.15 and a quick ratio of 0.91. The firm has a market cap of $6.25 billion, a PE ratio of 27.88, a price-to-earnings-growth ratio of 1.77 and a beta of 1.42. The company has a 50-day moving average of $38.64 and a two-hundred day moving average of $36.30. Envista Holdings Co. has a 1-year low of $31.67 and a 1-year high of $45.76.

Envista (NYSE:NVST – Get Rating) last announced its earnings results on Wednesday, February 8th. The company reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.03. The company had revenue of $660.80 million during the quarter, compared to analyst estimates of $658.40 million. Envista had a net margin of 9.46% and a return on equity of 8.52%. Envista’s revenue was up 1.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.46 earnings per share. On average, analysts predict that Envista Holdings Co. will post 1.9 EPS for the current year.

Envista Profile

(Get Rating)

Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands.